Rain Oncology Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Rain Oncology Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2023.
  • Rain Oncology Inc. Return On Equity for the quarter ending September 30, 2023 was -83 %, a 24% decline year-over-year.
  • Rain Oncology Inc. annual Return On Equity for 2022 was -74.4 %, a 44.2% decline from 2021.
  • Rain Oncology Inc. annual Return On Equity for 2021 was -51.6 %, a 168% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2023 -83 -16.1 -24% Jul 1, 2023 Sep 30, 2023
Q2 2023 -91.9 -33.7 -57.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -81.4 -36.9 -82.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -74.4 -22.8 -44.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -66.9 +0.47 +0.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -58.2 +184 +75.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.5 -119 -160% Jan 1, 2022 Mar 31, 2022
Q4 2021 -51.6 -127 -168% Oct 1, 2021 Dec 31, 2021
Q3 2021 -67.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -242 Apr 1, 2021 Jun 30, 2021
Q1 2021 74.6 Jan 1, 2021 Mar 31, 2021
Q4 2020 75.7 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.